Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.24.2.u1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Cash flows from operating activities              
Net loss $ (4,959,608) $ (4,649,635) $ (5,777,966) $ (4,477,778) $ (9,609,243) $ (10,255,744)  
Adjustments to reconcile net loss to net cash used in operating activities:              
Depreciation 6,569   159,204   13,137 164,247  
Stock-based compensation expense         84,131 248,118  
Changes in operating assets and liabilities:              
Accounts receivable         0 (39,721)  
Operating lease right-of-use assets         58,465 51,551  
Prepaid expenses and other current assets         30,719 (380,471)  
Prepaid research and development         (86,483) 692,387  
Accounts payable         875,701 (397,027)  
Operating lease liabilities         (62,389) (53,350)  
Accrued expenses and other current liabilities         (225,430) (567,509)  
Net cash used in operating activities         (8,921,392) (10,537,519)  
Cash flows from investing activities              
Purchases of equipment and improvements         0 (14,238)  
Purchases of investments - marketable securities         (9,209,545) (18,681,260)  
Maturities of investments - marketable securities         8,440,958 15,406,535  
Net cash used in investing activities         (768,587) (3,288,963)  
Cash flows from financing activities              
Proceeds from issuance of common stock, pre-funded warrants and warrants, net of issuance costs       1,000,000 3,611,255 8,543,037  
Net cash provided by financing activities         3,611,255 8,543,037  
Net decrease in cash and cash equivalents         (6,078,724) (5,283,445)  
Cash and cash equivalents at beginning of period   $ 9,165,179   $ 7,188,553 9,165,179 7,188,553 $ 7,188,553
Cash and cash equivalents at end of period $ 3,086,455   $ 1,905,108   3,086,455 1,905,108 $ 9,165,179
Supplemental disclosures of non-cash financing activities              
Non-cash financing costs         (181,930) 0  
Supplemental disclosures of cash flow information              
Issuance costs         $ 1,203,350 $ 1,456,479